Camp4 Therapeutics Corp — Form 8-K
Filed September 28, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Camp4 Therapeutics filed an 8-K on September 28, 2026, disclosing items under Regulation FD (Item 7.01), Other Events (Item 8.01), and Financial Statements/Exhibits (Item 9.01). The filing includes two exhibits (EX-99.1 and EX-99.2) comprising 56 graphic images and supplementary documents, but the substantive disclosure text is not presented in the provided filing metadata—only document structure and file listings are visible.
Why this rating
Unable to assess material impact; filing structure shows disclosure items exist but content is inaccessible. Without substance, significance defaults to routine administrative filing—a rounding error for $14.6M market-cap company.
Extracted items
- 7.01 Reg FD disclosure
- 8.01 other event
- 9.01 exhibits
See more from September 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.